Registration, quality assurance and the shape of a medicines contract
A medicines tender is decided on quality assurance before it is decided on price. Bidders must show that the product is authorised or registered for use in the destination market, that it is manufactured at a site holding current good manufacturing practice certification, and -- for many donor-funded and essential medicines programs -- that the product or its manufacturer appears on a recognised prequalification list. These are documentary conditions of admissibility assessed against the specific product and manufacturing site offered, and a change of site after award is a contractual event, not an administrative one.
Products are specified by international non-proprietary name, strength and dosage form so that generics compete openly, with pharmacopoeial standards cited for quality. Delivery conditions carry as much weight as the product: a minimum proportion of shelf life remaining on arrival, batch certificates of analysis, tamper-evident and correctly labelled packaging in the required language, and unbroken cold chain with temperature monitoring for products that need it. A consignment that arrives with too little shelf life left is routinely rejected at the buyer's cost to the supplier.
The commercial structure is usually a framework at agreed unit prices with call-offs against forecast rather than firm volume, because demand depends on disease patterns and program funding. That places emphasis on lead times, on the supplier's obligation to hold or replenish stock, and on what happens in a shortage -- allocation, substitution and notification terms are increasingly explicit. Recall capability is tested rather than assumed: buyers ask how quickly a batch can be traced and withdrawn from every facility it reached.
This section describes how this category is bought generally, across the public buyers that publish it. The figures elsewhere on this page are measured for this market alone.
Who buys pharmaceuticals in Brazil?
GlobalGov holds 414 pharmaceuticals records from 232 distinct buying organizations in Brazil. The most frequent publishers are Estado do Ceara (28 records); Municipio de Vargem Grande do Sul (28 records); Secretaria de Estado da Saude (17 records); Municipio de Vargem Grande do SUL (11 records); Fundo Municipal de Saude (7 records); Comando do Exercito (6 records). Between them the 6 largest account for 23% of everything published, so buying here is spread across many separate authorities.
| Buying organization | Records | Share |
|---|---|---|
| Estado do Ceara | 28 | 6.8% |
| Municipio de Vargem Grande do Sul | 28 | 6.8% |
| Secretaria de Estado da Saude | 17 | 4.1% |
| Municipio de Vargem Grande do SUL | 11 | 2.7% |
| Fundo Municipal de Saude | 7 | 1.7% |
| Comando do Exercito | 6 | 1.4% |
What are pharmaceuticals contracts worth in Brazil?
343 of the 414 records publish a contract value. The median is $4,560 and the largest single published value is $41.5M. By size, 255 under $100k, 63 between $100k and $1M, 23 between $1M and $10M, 2 above $10M. The remaining 71 publish no value at all, so every figure here describes the priced subset only, and values are as stated by the buyer rather than as finally awarded.
| Contract size | Records | Share of priced |
|---|---|---|
| under $100k | 255 | 74% |
| between $100k and $1M | 63 | 18% |
| between $1M and $10M | 23 | 6.7% |
| above $10M | 2 | 0.6% |
How long do bidders get to respond to pharmaceuticals tenders in Brazil?
Across the 230 Brazil pharmaceuticals notices that publish both a publication date and a closing date, the median response window is 17 days. A quarter of them allowed 13 days or fewer and a quarter stayed open for more than 20. 85 of them (37%) closed within a fortnight of being published, so on this market a bidder who reviews notices once a week can lose most of the response window before reading one.
How often are pharmaceuticals tenders published in Brazil?
Brazil publishes about 34 notices a month in this category, 411 in the last twelve months. Over the last three years there were 414, spread across 11 separate months of activity since 8 March 2024. November is historically the busiest month. The most recent was published 18 November 2026.
How does Brazil compare with other pharmaceuticals markets?
Among the 45 countries where GlobalGov holds a comparable pharmaceuticals market, Brazil ranks 23rd by number of records. The largest is Poland (9,417 records against 414 here). Within Brazil itself, pharmaceuticals is the 16th largest of the 33 procurement categories tracked here.
Where do the Brazil pharmaceuticals records on this page come from?
These 414 records are collected from 1 official source: PNCP (414). GlobalGov is an independent aggregator and is not affiliated with any of them; each record links back to the notice on its issuing portal. The set is rebuilt nightly, and the counts on this page were taken on 2026-11-22.
Open Pharmaceuticals tenders in Brazil
Showing 10 of the 68 notices open in this category today. Openness uses the same definition as the Brazil market page: active, not marked awarded, cancelled, closed or expired, and either closing in the future or published within the last 90 days with no stated closing date.
Price record minutes for the supply of medicine u2013 bevacizumab
Regular purchase of adalimumab medicine injectable solution 40MG vial ampoule or syringe filled AND OTHERS, in price registration system, to meet the needs of the Health Secretariat – DF, as specified and quantitative in Annex I of the Notice.
Price registration - medicine
Price registration - medicine
Acquisition of materials for APH-T kits, evidence bags and drug testing.
Price Registration for Drug Acquisition
Price registration for future and eventual acquisition of standardized drugs in the municipal relationship of essential drugs Remume, non-standard drugs in the Remume and medicines intended to meet lawsuits, aiming to ensure regular supply of the pharmaceutical supply center CAF and the continuity of pharmaceutical care provided by the municipal health secretariat.
The combined acquisition of a Generator Group and a Solar Power Plant to meet the operational demands of the Administrative Headquarters of the Regional Council of Medicine of the State of Roraima (CRM-RR). The measure is based on the following technical, operational and economic aspects.
Acquisition of computers for the Faculty of Veterinary Medicine of Araçatuba
Other procurement categories in Brazil
Pharmaceuticals procurement in other markets
Never Miss a Brazil Government Contract
Finding Brazil tenders usually means a local portal, a local registration and someone who reads the language. Get an alert you can read when a new pharmaceuticals opportunity is published there.
Start Free Trial